U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options ...Middle East

EMBLAVEOTM is the first and only monobactam/β-lactamase inhibitor combination antibiotic therapy approved by the U.S. FDA to treat complicated intra-abdominal infections, including those caused by Gram-negative bacteria Gram-negative bacterial infections represent a significant public...

Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options )

Also on site :

• Ben & Jerry's New Ice Cream Flavor Has Fans Saying the Same Thing
• Iconic '70s Rocker Releases First Album In Nearly a Decade
• 2 healthcare workers accused of elder abuse after woman, 92, found with broken bones